Medical/Pharmaceuticals

Inmagene launched U.S. subsidiary; Dr. Jean-Louis Saillot joined the company.

SAN DIEGO, Calif. and SHANGHAI, Feb. 2, 2021 /PRNewswire/ -- Inmagene Biopharmaceuticals ("Inmagene"), a leading biotech company focused on immunology-related therapeutic areas, today announced the launch of its wholly-owned subsidiary inSan Diego. Jean-Louis Saillot, MD has joined the company a...

2021-02-02 14:48 2111

CF PharmTech and Chengdu Shangyi Launch the "Home-Based Recovery Program for Discharged Covid-19 Patients" and Announce Today's Global Release of the "R Plus Health" Free App

SUZHOU, China, Feb. 2, 2021 /PRNewswire/ -- CF PharmTech, Inc. is a fully integrated pharmaceutical company inChina specializing in the treatment of respiratory diseases. Chengdu Shangyi Information Technology Co., Ltd is a professional IT service company in the healthcare industry inChina.

2021-02-02 09:00 2508

MedTech Startup See-Mode Technologies Announces CE Mark and Australian TGA Approval for AI-powered Ultrasound Analysis Software

SINGAPORE and MELBOURNE, Australia, Feb. 2, 2021 /PRNewswire/ -- See-Mode Technologies , a MedTech startup based in Singapore andAustralia that seeks to empower clinicians to better predict stroke, today announced that it has received two more regulatory approvals – the...

2021-02-02 06:00 3721

Crafoord Laureate discovered the explanation for mysterious fevers

STOCKHOLM, Feb. 1, 2021 /PRNewswire/ -- Dan Kastner, USA, has described an entirely new group of rare autoinflammatory diseases. His discoveries have brought new knowledge and led to the development of effective treatments. The Royal Swedish Academy of Sciences is awarding him this year's Crafoor...

2021-02-01 21:06 1152

Wondfo - Neutralizing antibody testing, antigen testing and PCR key in battle against COVID-19 in 2021

GUANGZHOU, China, Feb. 1, 2021 /PRNewswire/ -- Wondfo is ramping up neutralizing antibody, antigen and PCR tests to address the evolving demands for COVID-19 testing globally. As countries draw up plans to deal with the new wave of infections amidst the pandemic while vaccination programmes are r...

2021-02-01 20:38 2222

Assisted Reproduction Unicorn Basecare Medical to IPO in Hong Kong

SUZHOU, China, Feb. 1, 2021 /PRNewswire/ -- Suzhou Basecare Medical Co., Ltd. (Basecare Medical) — set to list on the Hong Kong Stock Exchange onFebruary 8th , 2021— is the newest unicorn in the field of assisted reproduction. The planned IPO comes after a very successful and profitable 2020, favo...

2021-02-01 15:20 5512

Clover and Dynavax Announce Planned Global Phase 2/3 Efficacy Trial of Adjuvanted COVID-19 Vaccine Candidate

* Clover plans to initiate a global Phase 2/3 efficacy trial of its protein-based S-Trimer COVID-19 vaccine candidate adjuvanted with Dynavax's CpG 1018 plus alumin the first half of 2021 with an interim analysis for vaccine efficacy potentially in the middle of 2021. * The Coalition for Epid...

2021-02-01 14:00 5357

Seegene develops world first COVID-19 variant test capable of identifying origins of virus variants

* SEEGENE ROLLS OUT FIRST COVID-19 MUTANT IDENTIFICATION TEST * COVID-19 TEST MANUFACTURER CONTINUES TRACKING VARIANTS * S. KOREAN FIRM COMMITTED TO WORKING WITH GOVERNMENTS SEOUL, South Korea, Feb. 1, 2021 /PRNewswire/ -- South Korea's biotechnology firm Seegene (KQ096530) said Monday it ...

2021-02-01 13:05 3002

Cytiva acquires Vanrx Pharmasystems, Canadian aseptic filling innovator

- Cytiva will now provide "idea to injection" solutions to customers and the market - Addition to portfolio supports global trends towards smaller manufacturing and the advent of personalized therapies - First acquisition by company since becoming Cytiva in April 2020 AMERSHAM, United Kingdom, ...

2021-02-01 13:01 2980

INEOS Styrolution Receives "2020 Public Welfare Practice Award" at the 10th China Charity Festival

SINGAPORE, Feb. 1, 2021 /PRNewswire/ -- INEOS Styrolution, the global leader in styrenics, today announces that it has been awarded the "2020 Public Welfare Practice Award" at the 10th China Charity Festival held on 29th January 2021, in Shanghai.

2021-02-01 09:00 2325

Antengene Announces Collaboration with WuXi Biologics and WuXi STA to Advance Antibody-Drug Conjugate Candidate into Clinical-stage

SHANGHAI and HONG KONG, Feb. 1, 2021 /PRNewswire/ -- Antengene Corporation Limited ("Antengene", SEHK: 6996.HK), a leading innovative biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and/or best-in-class therapeutics in hematology and oncolo...

2021-02-01 08:09 4319

Phase 1 Drug Candidate GLR2007 Developed by Gan & Lee has been Granted Fast Track Designation by the U.S. FDA

BEIJING and BRIDGEWATER, N.J., Jan. 29, 2021 /PRNewswire/ -- Gan & Lee Pharmaceuticals Co., Ltd. (hereinafter referred to as Gan & Lee) (Shanghai: 603087.SH), a global biopharmaceutical company, today announced that the U.S. Food and Drug Administration (FDA) has granted Fast Track Designation fo...

2021-01-29 22:53 5874

RedHill Biopharma Announces Positive DSMB Futility Review for Phase 2/3 COVID-19 Study of Opaganib

TEL AVIV, Israel and RALEIGH, N.C., Jan. 29, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced that the independent Data Safety Monitoring Board (DSMB) for the globa...

2021-01-29 20:26 6004

2021 Japan Prize Laureates Announced

TOKYO, Jan. 29, 2021 /PRNewswire/ -- The winners of the 2021 Japan Prize were announced onJanuary 29 by the Japan Prize Foundation and its president, Hiroshi Komiyama. The newest laureates are Australian researcher Prof. Martin Andrew Green, honored for his work in the field of "Resources, Energy...

2021-01-29 14:00 590

Ascentage Pharma Announces the Fifth Orphan Drug Designation Granted to Bcl-2 Inhibitor APG-2575 by the US FDA, and the Tenth Obtained by the Company

SUZHOU, China and ROCKVILLE, Md., Jan. 29, 2021 /PRNewswire/ -- Ascentage Pharma (6855.HK), a globally focused, clinical-stage biotechnology company engaged in developing novel therapies for cancers, chronic hepatitis B (CHB), and age-related diseases, today announced that the US Food and Drug A...

2021-01-29 08:29 1783

12-Month Below-the-Knee Data with MedAlliance's SELUTION SLR™ Presented as Late Breaking Trial at LINC

NYON, Switzerland, Jan. 29, 2021 /PRNewswire/ -- 12-month results from the PRESTIGE* Below-the-Knee (BTK) study have been presented as a Late Breaking Trial at LINC 2021. The objective of this clinical investigation has been to evaluate safety and performance outcomes of SELUTION SLR™, MedAllianc...

2021-01-29 01:46 738

RedHill Biopharma Further Expands Opaganib Manufacturing Capacity for COVID-19 with Cosmo Pharmaceuticals

TEL AVIV, Israel and RALEIGH, N.C., Jan. 28, 2021 /PRNewswire/ -- RedHill Biopharma Ltd. (Nasdaq: RDHL) ("RedHill" or the "Company"), a specialty biopharmaceutical company, today announced a manufacturing agreement with Cosmo Pharmaceuticals NV (SIX: COPN) ("...

2021-01-28 22:03 4927

Covid-T™ Clinical Development Program Initiated Regulatory Advisory Group Engaged

VANCOUVER, BC, Jan. 28, 2021 /PRNewswire/ -- BioVaxys Technology Corp. (CSE: BIOV) (FRA: 5LB) (OTC: LMNGF) ("BioVaxys" or "Company") is pleased to announce that it has initiated the clinical development program for Covid-T™, the Company's novel diagnostic platform for detecting T-cell activity. T...

2021-01-28 21:46 4885

Zeus Launches Reinforced Polyimide Tubing

Expanded Capabilities Help Customers Consolidate Suppliers, Innovate, and Go to Market With Confidence ORANGEBURG, S.C., Jan. 28, 2021 /PRNewswire/ -- Zeus Industrial Products, Inc. (Zeus), a leading polymer solutions provider and material science innovator, announced today that it has added bra...

2021-01-28 21:00 1417

Clinical Trial of Proxalutamide's Trial of Hospitalized Covid-19 Patients Was Approved in Brazil

SUZHOU, China, Jan. 28, 2021 /PRNewswire/ -- Kintor Pharmaceutical Limited (HKEX: 9939) is pleased to announce that the clinical trial (the "Trial") of Proxalutamide's treatment of hospitalized COVID-19 patients was approved by the Institutional Review Board ("IRB") ofBrazil. The trial was accept...

2021-01-28 19:57 5939
1 ... 270271272273274275276 ... 383